Company / SG&A Expense
Cardinal Health SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$5.4B
FY2025
5-year range
$4.5B / $5.4B
FY2021-FY2025
Trend
+7.6%
vs FY2024
Sector context
#14 of 158
Health Care
What the data says
Among 158 Health Care companies, Cardinal Health is in the bottom 9% for sg&a expense. SG&A Expense has increased for 4 consecutive years, from $4.5B in FY2021 to $5.4B in FY2025.
Based on SEC 10-K filings.
$5.4B in FY2025 with a 5-year CAGR of +3.2%. Top quartile in the Health Care sector.
Increased from $4.8B to $5.4B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +6.1%
- 5-Year CAGR
- +3.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 158This company $5.4B Sector average $175.9B
▼
-96.9% below sector average
Key checks
Key Insights
- Cardinal Health's sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +3.2%, indicating consistent growth.
- In FY2025, sg&a expense increased 7.6% year-over-year.
- Ranks #14 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.27 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.4B | +7.6% |
| FY2024 | $5.0B | +4.2% |
| FY2023 | $4.8B | +6.4% |
| FY2022 | $4.5B | +0.7% |
| FY2021 | $4.5B | -2.5% |
| FY2020 | $4.6B | +21.7% |
| FY2019 | $3.8B | -17.9% |
| FY2018 | $4.6B | +41.9% |
| FY2017 | $3.2B | +7.0% |
| FY2016 | $3.0B | -6.5% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026